April 7, 2022
April 7, 2022 —
Asian and Hispanic communities experience significantly more air pollution from economic activity compared to predominantly white neighborhoods across the state of California, according to new research from the University of California San Diego’s School of Global Policy and Strategy.
April 6, 2022
April 6, 2022 —
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
April 4, 2022
April 4, 2022 —
Charitable giving increased in counties that experienced COVID-19-related deaths, reveals a new study from the University of California San Diego’s Rady School of Management published in Nature’s Scientific Reports.
March 29, 2022
March 29, 2022 —
Financial markets are more efficient than some speculators may want to believe. When it comes to predicting the performance of markets, everyone wants an edge. Getting such an edge is achievable, but it will be impossible to maintain over time, according to research from UC San Diego's Rady School.
March 28, 2022
March 28, 2022 —
UC San Diego Health receives “LGBTQ+ Healthcare Equality Leader” designation by the Human Rights Campaign Foundation for policies and practices dedicated to the equitable treatment and inclusion of LGBTQ+ patients, visitors and employees.
March 22, 2022
March 22, 2022 —
A UC San Diego pilot study on parents of mass shooting victims finds that eight weeks of mindfulness training is effective in reducing trauma, depression, stress and grief caused by gun violence.
March 21, 2022
March 21, 2022 —
UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.
March 21, 2022
March 21, 2022 —
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
March 17, 2022
March 17, 2022 —
UC San Diego study shows neuroendocrine cells in the lungs drive a developmental lung disease, and a similar brain-lung interaction may contribute to COVID-19 symptoms. The findings suggest neuropeptides may be a promising therapeutic target for conditions with excess lung fluid.
March 17, 2022
March 17, 2022 —
The All of Us Research Program, a nationwide effort to gather information from 1 million or more people living in the United States, then use that data to accelerate health research and medical breakthroughs, has published its first genomic dataset.
